HK1156077A1 - Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides - Google Patents
Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptidesInfo
- Publication number
- HK1156077A1 HK1156077A1 HK11110367.1A HK11110367A HK1156077A1 HK 1156077 A1 HK1156077 A1 HK 1156077A1 HK 11110367 A HK11110367 A HK 11110367A HK 1156077 A1 HK1156077 A1 HK 1156077A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- urlc10
- lung cancers
- peptide vaccines
- cancers expressing
- expressing ttk
- Prior art date
Links
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 229940023041 peptide vaccine Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65685705P | 2005-02-25 | 2005-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1156077A1 true HK1156077A1 (en) | 2012-06-01 |
Family
ID=36570330
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11110367.1A HK1156077A1 (en) | 2005-02-25 | 2011-09-30 | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
HK11110363.5A HK1156076A1 (en) | 2005-02-25 | 2011-09-30 | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11110363.5A HK1156076A1 (en) | 2005-02-25 | 2011-09-30 | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
Country Status (10)
Country | Link |
---|---|
US (2) | US7847060B2 (es) |
EP (3) | EP2325305B1 (es) |
JP (5) | JP4461179B2 (es) |
DE (1) | DE602006021283D1 (es) |
DK (2) | DK2325306T3 (es) |
ES (3) | ES2459466T3 (es) |
HK (2) | HK1156077A1 (es) |
PL (2) | PL2325305T3 (es) |
PT (2) | PT2325305E (es) |
WO (1) | WO2006090810A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
EP2468887A1 (en) * | 2006-12-13 | 2012-06-27 | Oncotherapy Science, Inc. | TTK as tumor marker and therapeutic target for lung cancer |
TWI596109B (zh) * | 2007-02-21 | 2017-08-21 | 腫瘤療法 科學股份有限公司 | 表現腫瘤相關抗原之癌症的胜肽疫苗 |
AU2012261723B2 (en) * | 2007-02-21 | 2014-11-27 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing tumor-associated antigens |
JP2010535014A (ja) * | 2007-07-30 | 2010-11-18 | オンコセラピー・サイエンス株式会社 | 癌関連遺伝子ly6k |
RU2483078C2 (ru) | 2007-08-20 | 2013-05-27 | Онкотерапи Сайенс, Инк. | Cdh3-пептид и включающее его лекарственное средство |
TWI543767B (zh) * | 2008-08-19 | 2016-08-01 | 腫瘤療法 科學股份有限公司 | Hig2與urlc10抗原決定位胜肽以及含此胜肽之疫苗 |
TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
SG195571A1 (en) | 2008-10-22 | 2013-12-30 | Oncotherapy Science Inc | Rab6kifl/kif20a epitope peptide and vaccines containing the same |
TWI500932B (zh) | 2008-12-05 | 2015-09-21 | Oncotherapy Science Inc | Wdrpuh抗原決定位胜肽以及含此胜肽之疫苗 |
CA2747686A1 (en) | 2008-12-24 | 2010-07-01 | Oncotherapy Science, Inc. | C1orf59 peptides and vaccines including the same |
MX2011008917A (es) * | 2009-03-04 | 2011-09-09 | Oncotherapy Science Inc | Peptidos vangl1 y vacunas que incluyen los mismos. |
TW201100090A (en) * | 2009-04-01 | 2011-01-01 | Oncotherapy Science Inc | C6orf167 peptides and vaccines containing the same |
TW201102081A (en) * | 2009-05-11 | 2011-01-16 | Oncotherapy Science Inc | TTK peptides and vaccines including the same |
PT2474315T (pt) * | 2009-09-03 | 2018-03-15 | Toray Industries | Indutor de imunidade |
TW201124530A (en) * | 2009-12-01 | 2011-07-16 | Oncotherapy Science Inc | IMP-3 oligopeptides and vaccines including the same |
TW201200525A (en) * | 2009-12-04 | 2012-01-01 | Oncotherapy Science Inc | MYBL2 peptides and vaccines containing the same |
WO2012032763A1 (en) * | 2010-09-07 | 2012-03-15 | Oncotherapy Science, Inc. | Vangl1 peptides and vaccines including the same |
KR20140138900A (ko) * | 2012-03-09 | 2014-12-04 | 온코세라피 사이언스 가부시키가이샤 | 펩티드를 포함한 의약 조성물 |
EP2872531A4 (en) * | 2012-07-10 | 2016-04-06 | Oncotherapy Science Inc | LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME |
TWI643867B (zh) | 2013-05-24 | 2018-12-11 | 日商腫瘤療法 科學股份有限公司 | 對於th1細胞之imp-3抗原決定位胜肽及含此之疫苗 |
BR112017002206A2 (pt) | 2014-08-04 | 2017-11-21 | Oncotherapy Science Inc | peptídeo derivado de koc1 e vacina incluindo o mesmo |
AU2015300260B2 (en) | 2014-08-04 | 2020-01-02 | Oncotherapy Science, Inc. | URLC10-derived peptide and vaccine containing same |
WO2016080367A1 (ja) * | 2014-11-18 | 2016-05-26 | 塩野義製薬株式会社 | 安定化されたペプチド組成物 |
WO2021060343A1 (ja) * | 2019-09-24 | 2021-04-01 | オンコセラピー・サイエンス株式会社 | Urlc10由来ペプチドまたはdepdc1由来ペプチドを認識するヒトt細胞が発現するt細胞受容体 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5922687A (en) | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
EP0841945B1 (en) | 1995-08-03 | 2006-03-08 | Rijksuniversiteit te Leiden | Cell derived antigen presenting vesicles |
US5853719A (en) | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
US6294378B1 (en) | 1996-07-26 | 2001-09-25 | Sloan-Kettering Institute For Cancer Research | Method and reagents for genetic immunization |
WO1998045428A1 (de) | 1997-04-07 | 1998-10-15 | Roche Diagnostics Gmbh | Fanconi-gen ii |
DE59803082D1 (en) | 1997-04-07 | 2002-03-21 | Roche Diagnostics Gmbh | Fanconi-gen ii |
FR2766205B1 (fr) | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede |
US6255055B1 (en) | 1998-03-09 | 2001-07-03 | Wisconsin Alumni Research Foundation | c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence |
US20030236209A1 (en) | 1998-03-18 | 2003-12-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20030045491A1 (en) | 2001-02-23 | 2003-03-06 | Christoph Reinhard | TTK in diagnosis and as a therapeutic target in cancer |
US20020119156A1 (en) | 2000-03-29 | 2002-08-29 | Sei-Yu Chen | Compositions and methods of diagnosing, monitoring, staging, imaging and treating lung cancer |
MXPA03003151A (es) | 2000-10-13 | 2003-08-19 | Eos Biotechnology Inc | Metodos de diagnostico de cancer de prostata, composiciones y metodos para seleccionar moduladores de cancer de prostata. |
AU2002220265A1 (en) * | 2000-11-03 | 2002-05-15 | University Of Vermont And State Agricultural College | Compositions for inhibiting grb7 |
WO2002068444A1 (en) * | 2001-02-21 | 2002-09-06 | Chiron Corporation | Ttk in diagnosis and as a therapeutic target in cancer |
EP1463928A2 (en) | 2001-04-18 | 2004-10-06 | Protein Design Labs | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
US7189507B2 (en) * | 2001-06-18 | 2007-03-13 | Pdl Biopharma, Inc. | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
MXPA04003382A (es) | 2001-10-31 | 2004-11-22 | Pfizer Prod Inc | Agentes terapeuticos y diagnostico para transtornos de la eritropoyesis. |
US20030232350A1 (en) * | 2001-11-13 | 2003-12-18 | Eos Biotechnology, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
WO2003042661A2 (en) | 2001-11-13 | 2003-05-22 | Protein Design Labs, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
EP1497454A2 (en) | 2001-11-13 | 2005-01-19 | Protein Design Labs, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
EP1534739A4 (en) | 2002-01-18 | 2006-05-31 | Bristol Myers Squibb Co | IDENTIFICATION OF POLYNUCLEOTIDES AND POLYPEPTIDES FOR PREDICTING THE ACTIVITY OF COMPOUNDS THAT INTERACT WITH TYROSINE KINASE PROTEINS AND / OR TYROSINE KINASE PROTEIN PATHWAYS |
CN101613405A (zh) * | 2002-06-06 | 2009-12-30 | 肿瘤疗法科学股份有限公司 | 与人结肠癌相关的基因和多肽 |
CN103951745A (zh) * | 2002-09-12 | 2014-07-30 | 肿瘤疗法科学股份有限公司 | Kdr肽和包括该肽的疫苗 |
US20060024692A1 (en) | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
TW200413725A (en) | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
ATE505538T1 (de) | 2003-06-09 | 2011-04-15 | Corixa Corp | Dna-vektoren |
JP4721903B2 (ja) * | 2004-01-29 | 2011-07-13 | 大日本住友製薬株式会社 | 新規腫瘍抗原蛋白質及びその利用 |
JP2005230011A (ja) | 2004-02-20 | 2005-09-02 | Samsung Electronics Co Ltd | 乳ガン関連蛋白質、それをコーディングする遺伝子、及び該蛋白質及び該遺伝子を利用した乳ガンの診断方法 |
ATE496142T1 (de) * | 2004-03-23 | 2011-02-15 | Oncotherapy Science Inc | Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs |
EP1854473A1 (en) | 2005-03-03 | 2007-11-14 | Takeda Pharmaceutical Company Limited | Preventive/therapeutic agent for cancer |
EP2468887A1 (en) * | 2006-12-13 | 2012-06-27 | Oncotherapy Science, Inc. | TTK as tumor marker and therapeutic target for lung cancer |
JP2010535014A (ja) * | 2007-07-30 | 2010-11-18 | オンコセラピー・サイエンス株式会社 | 癌関連遺伝子ly6k |
TW201008574A (en) * | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
-
2006
- 2006-02-17 ES ES10010439.7T patent/ES2459466T3/es active Active
- 2006-02-17 DK DK10010439.7T patent/DK2325306T3/en active
- 2006-02-17 EP EP10010438.9A patent/EP2325305B1/en active Active
- 2006-02-17 ES ES06714493T patent/ES2364670T3/es active Active
- 2006-02-17 ES ES10010438.9T patent/ES2459492T3/es active Active
- 2006-02-17 PT PT100104389T patent/PT2325305E/pt unknown
- 2006-02-17 PL PL10010438T patent/PL2325305T3/pl unknown
- 2006-02-17 WO PCT/JP2006/303354 patent/WO2006090810A2/en active Application Filing
- 2006-02-17 PL PL10010439T patent/PL2325306T3/pl unknown
- 2006-02-17 PT PT100104397T patent/PT2325306E/pt unknown
- 2006-02-17 DE DE602006021283T patent/DE602006021283D1/de active Active
- 2006-02-17 US US11/816,616 patent/US7847060B2/en active Active
- 2006-02-17 JP JP2007531118A patent/JP4461179B2/ja active Active
- 2006-02-17 EP EP10010439.7A patent/EP2325306B1/en active Active
- 2006-02-17 EP EP06714493A patent/EP1853703B1/en not_active Not-in-force
- 2006-02-17 DK DK10010438.9T patent/DK2325305T3/en active
-
2009
- 2009-03-12 JP JP2009058802A patent/JP4493054B2/ja active Active
- 2009-03-12 JP JP2009058801A patent/JP2009173661A/ja active Pending
- 2009-03-12 JP JP2009058798A patent/JP4493053B2/ja active Active
- 2009-12-25 JP JP2009295766A patent/JP2010143924A/ja active Pending
-
2010
- 2010-10-13 US US12/903,961 patent/US8614176B2/en active Active
-
2011
- 2011-09-30 HK HK11110367.1A patent/HK1156077A1/xx not_active IP Right Cessation
- 2011-09-30 HK HK11110363.5A patent/HK1156076A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK2325305T3 (en) | 2014-03-03 |
PL2325305T3 (pl) | 2014-07-31 |
PL2325306T3 (pl) | 2014-07-31 |
JP2008530975A (ja) | 2008-08-14 |
JP4493053B2 (ja) | 2010-06-30 |
DE602006021283D1 (de) | 2011-05-26 |
US20090202576A1 (en) | 2009-08-13 |
EP2325305A1 (en) | 2011-05-25 |
ES2364670T3 (es) | 2011-09-12 |
EP1853703B1 (en) | 2011-04-13 |
ES2459492T3 (es) | 2014-05-09 |
PT2325306E (pt) | 2014-04-29 |
ES2459466T3 (es) | 2014-05-09 |
EP2325306B1 (en) | 2014-02-12 |
EP1853703A2 (en) | 2007-11-14 |
JP4493054B2 (ja) | 2010-06-30 |
EP2325306A1 (en) | 2011-05-25 |
JP2009173662A (ja) | 2009-08-06 |
WO2006090810A3 (en) | 2007-03-29 |
JP2009173661A (ja) | 2009-08-06 |
US7847060B2 (en) | 2010-12-07 |
DK2325306T3 (en) | 2014-03-03 |
HK1156076A1 (en) | 2012-06-01 |
US8614176B2 (en) | 2013-12-24 |
PT2325305E (pt) | 2014-04-29 |
US20110027302A1 (en) | 2011-02-03 |
JP4461179B2 (ja) | 2010-05-12 |
EP2325305B1 (en) | 2014-02-12 |
JP2010143924A (ja) | 2010-07-01 |
WO2006090810A2 (en) | 2006-08-31 |
JP2009173660A (ja) | 2009-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1156076A1 (en) | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides | |
HK1171026A1 (en) | Peptide vaccines for cancers expressing depdc1 polypeptides depdc1 | |
GB0524788D0 (en) | Polypeptides | |
EG25313A (en) | Improved dry powder inhaler. | |
GB0520794D0 (en) | Inhaler | |
IL186698A0 (en) | Breath actuated inhaler | |
GB0519151D0 (en) | Inhaler | |
GB0518355D0 (en) | An inhaler | |
EP1859828A4 (en) | INHALER | |
GB0508863D0 (en) | Peptide | |
EP1735335A4 (en) | Cell-destroying peptides | |
IL186880A0 (en) | Evolved interferon alpha polypeptides | |
EP1765392A4 (en) | POLYPETPIDES INDUCING APOPTOSIS | |
GB0524194D0 (en) | Respirable powders | |
IL196292A0 (en) | Csf3r polypeptides, their preparation and uses thereof | |
GB0505949D0 (en) | Polypeptides | |
GB0526120D0 (en) | Therapeutic peptides | |
GB0526019D0 (en) | Peptides | |
GB0516527D0 (en) | Peptides | |
GB0510091D0 (en) | Inhaler | |
EP1881843A4 (en) | KINASEPEPTIDES AND ANTIBODIES | |
GB0511861D0 (en) | Proteins | |
ATE505536T1 (de) | Peptid-impfstoff für lungenkrebs, der ttk polypeptide exprimiert | |
GB0508866D0 (en) | Soluble polypeptide | |
GB0504769D0 (en) | Polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230217 |